Realizing drug repositioning by adapting a recommendation system to handle the process

BackgroundDrug repositioning is the process of identifying new targets for known drugs. It can be used to overcome problems associated with traditional drug discovery by adapting existing drugs to treat new discovered diseases. Thus, it may reduce associated risk, cost and time required to identify and verify new drugs. Nowadays, drug repositioning has received more attention from industry and academia. To tackle this problem, researchers have applied many different computational methods and have used various features of drugs and diseases.ResultsIn this study, we contribute to the ongoing research efforts by combining multiple features, namely chemical structures, protein interactions and side-effects to predict new indications of target drugs. To achieve our target, we realize drug repositioning as a recommendation process and this leads to a new perspective in tackling the problem. The utilized recommendation method is based on Pareto dominance and collaborative filtering. It can also integrate multiple data-sources and multiple features. For the computation part, we applied several settings and we compared their performance. Evaluation results show that the proposed method can achieve more concentrated predictions with high precision, where nearly half of the predictions are true.ConclusionsCompared to other state of the art methods described in the literature, the proposed method is better at making right predictions by having higher precision. The reported results demonstrate the applicability and effectiveness of recommendation methods for drug repositioning.

[1]  Pankaj Agarwal,et al.  Systematic Drug Repositioning Based on Clinical Side-Effects , 2011, PloS one.

[2]  Priya Nambisan,et al.  Using Social Media Data to Identify Potential Candidates for Drug Repurposing: A Feasibility Study , 2016, JMIR research protocols.

[3]  Mark Goadrich,et al.  The relationship between Precision-Recall and ROC curves , 2006, ICML.

[4]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[5]  Guanghui Hu,et al.  Human Disease-Drug Network Based on Genomic Expression Profiles , 2009, PloS one.

[6]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[7]  Jacob K. Asiedu,et al.  The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.

[8]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[9]  G. Schneider,et al.  Predicting Compound Selectivity by Self‐Organizing Maps: Cross‐Activities of Metabotropic Glutamate Receptor Antagonists , 2006, ChemMedChem.

[10]  David S. Wishart,et al.  Nucleic Acids Research Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs Polysearch: a Web-based Text Mining System for Extracting Relationships between Human Diseases, Genes, Mutations, Drugs and Metabolites , 2008 .

[11]  Sonia Farhana Nimmy,et al.  StrucBreak: A Computational Framework for Structural Break Detection in DNA Sequences , 2017, Interdisciplinary Sciences: Computational Life Sciences.

[12]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[13]  Nilanjan Dey,et al.  De-Bruijn graph with MapReduce framework towards metagenomic data classification , 2017 .

[14]  Gianfranco Balbo,et al.  Exploiting flow equivalent server in transient analysis , 2016, Comput. Syst. Sci. Eng..

[15]  Nilanjan Dey,et al.  Hidden Markov model and Chapman Kolmogrov for protein structures prediction from images , 2017, Comput. Biol. Chem..

[16]  Nataša Pržulj,et al.  Methods for biological data integration: perspectives and challenges , 2015, Journal of The Royal Society Interface.

[17]  Yi Pan,et al.  Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm , 2016, Bioinform..

[18]  Gerd Geisslinger,et al.  Drug Repurposing for the Development of Novel Analgesics. , 2016, Trends in pharmacological sciences.

[19]  Reda Alhajj,et al.  Multi-objective optimization based location and social network aware recommendation , 2014, 10th IEEE International Conference on Collaborative Computing: Networking, Applications and Worksharing.

[20]  Di He,et al.  Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing , 2016, PLoS Comput. Biol..

[21]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[22]  Dragomir R. Radev,et al.  Identifying gene-disease associations using centrality on a literature mined gene-interaction network , 2008, ISMB.

[23]  A. Chiang,et al.  Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses , 2009, Clinical pharmacology and therapeutics.

[24]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[25]  Mohammed Al-Shalalfa,et al.  Prediction of novel drug indications using network driven biological data prioritization and integration , 2014, Journal of Cheminformatics.

[26]  Xiaoyan Zhu,et al.  Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts , 2009, PLoS Comput. Biol..

[27]  Alexander A. Morgan,et al.  Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.

[28]  Anton Yuryev,et al.  Computational Approaches for Drug Repositioning and Combination Therapy Design , 2010, J. Bioinform. Comput. Biol..

[29]  Sazia Parvin,et al.  Performance evaluation comparison for detecting DNA structural break through big data analysis , 2016, Comput. Syst. Sci. Eng..

[30]  Nasser Ghadiri,et al.  A review of network‐based approaches to drug repositioning , 2018, Briefings Bioinform..

[31]  Zoran Obradovic,et al.  Computational Drug Repositioning by Ranking and Integrating Multiple Data Sources , 2013, ECML/PKDD.

[32]  Lisa Bastarache,et al.  Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics. , 2017, Assay and drug development technologies.

[33]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[34]  Joel Dudley,et al.  Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..

[35]  Nilanjan Dey,et al.  Evolutionary framework for coding area selection from cancer data , 2018, Neural Computing and Applications.

[36]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[37]  Luonan Chen,et al.  Network-based drug repositioning. , 2013, Molecular bioSystems.

[38]  Reda Alhajj,et al.  Inference of gene regulatory networks via multiple data sources and a recommendation method , 2015, 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[39]  Zhiyong Lu,et al.  A new method for computational drug repositioning using drug pairwise similarity , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine.